Faulty Diagnosis Phase definition

Faulty Diagnosis Phase. Let h (1≤h≤n) be a fault-free processor. h can detect processor k (1≤k≤n) as faulty if: F1: h receives the λ from k (or no message is received from k) and the number of copies of k is greater than (n-1- fd)/3, then processor Pk as dormant faulty processor; F2: For each Ti If val(αk) ≠ majority value maj(α), then *fk = *fk + 1 Next If *fk > (n-1- fd )/3, then processor Pk as arbitrary processor; F3: If fk < (n-1- fd)/3 and fa< (n-1- fd)/3, then For each Ti For 1 to k *fα = *fα + 1 Next Next If *fα > (n-1- fd)/3, then processor Pα as arbitrary faulty processor; F : Compute the T k−1 by taking the majority on each T k (i ⊄ f ) 4 i i a If val( T k−1 ) ≠ val( T k−1 ) (i ≠ j) and f < (n-1- f )/3, then the source s as arbitrary faulty processor.
View Source

Related to Faulty Diagnosis Phase

  • Diagnosis means the definition of the nature of the Client's disorder. When formulating the Diagnosis of Client, CONTRACTOR shall use the diagnostic codes and axes as specified in the most current edition of the DSM published by the American Psychiatric Association. DSM diagnoses will be recorded on all IRIS documents, as appropriate.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.